💡BSGM continues to build momentum 💪

As the markets turn higher this afternoon, make sure you keep your eye on BSGM as well. --------------------------------------------------------------- *Sponsored by Lifewater Media. Please see disclosures below. Hey, it’s Jeff Bishop again.  I am about to head into my weekly LIVE option training session @ 2pm EST. It is usually available only to members only, but I wanted to let you know that you’re invited today at absolutely no cost. You can join me in the “Bookie Room” right here @ 2pm EST:  [( For this week’s new idea on BioSig Technologies (Nasdaq: BSGM) it is taking a little breather after the big 10% jump yesterday. The stock is only down a few pennies, so I am not too concerned about it. The stock is actually trading off of the morning lows, and the overall market is starting to turn higher, so who knows where that could take things. I know the idea I had last week followed a similar pattern before it jumped even more in the following days. There are no guarantees in life or trading, of course, but recall some of the recent ideas I’ve shared with you that started off very similar to this and then went on to make moves of 17%, 36%, 40%, or more in the following days. I cam across this analyst forecast this afternoon on [TipRanks](. It’s only one data point, but this analyst has a price target on BSGM that is over 370% higher than the current price! With all of the great news, technical indicators, and strong analyst coverage, it looks like I’m in good company on BioSig Technologies (Nasdaq: BSGM). By the way, if you missed the email I sent out yesterday, I copied the highlights of it below so you can get up-to-speed with BioSig Technologies (Nasdaq: BSGM) today. ************************************ One of the great things about medical devices is that the FDA clearance hurdle is much lower than it is for drug makers. Case in point, BioSig Technologies’ (Nasdaq: BSGM) first product, the PURE EP™ System, is an FDA 510(k) cleared non-invasive class II device, that provides superior, real-time signal visualization allowing physicians to perform insight-based, highly targeted cardiac ablation procedures with increased procedural efficiency and efficacy. (1) This means it has already passed the tests and is ready to go! In fact, to date, physicians have [completed approximately 3000 patient cases]( with the BioSig Technologies’ (Nasdaq: BSGM) System. But first, let’s focus on the price action this year so far. Just look at this chart where I have highlighted the direction changes that were signaled by my custom indicators…   Nothing in trading is completely “predictable,” but notice how every time this year the stock has made a major move higher after the indicators crossed over and the stock traded above them? Well, right now, we are on the verge of another crossover event. The stock has entered a consolidation phase and is now starting to wake up. If you look at previous events, those upward moves have been absolutely explosive. 💥 To put it in perspective, just look at how BioSig Technologies (Nasdaq: BSGM) has performed this year vs the SPY. $1000 invested in BSGM at the start of the year would now be over $2500. 💰 $1000 invested in SPY at the same time would be $1080. This is why it is so important to pay attention to the right stocks and make sure you follow them closely. Small stocks like this just have incredible potential right now, if the catalyst is right. Even SeekingAlpha seems to agree with me. Look at this perfect “A rating” they show right now for BioSig Technologies (Nasdaq: BSGM) when it comes to momentum (2)… That is probably why all analysts covering the stock have it rated “BUY” or “STRONG BUY” right now. And get this… the [average analyst rating]( puts a price target for BioSig Technologies (Nasdaq: BSGM) over 300% higher than where it is today (3). When a stock is only trading for “pocket change,” like BSGM, it certainly doesn’t take a lot for it to reach those kinds of price targets.  These analysts should know what they are talking about. It is their job, after all. I hope they are right! I can see why analysts are starting to wake up to the story with BioSig Technologies (Nasdaq: BSGM) as well. Their main [product has a massive market opportunity](, it has cleared FDA approval, and now sales are starting to ramp up! (4) I love the price chart right now and the trading action lately. It is awesome to see analysts onboard with this too. The technicals look pristine to me. But, I have to say one of the things I like most here is the fact that we have seen such [strong insider buying]( (5).  Every executive will talk a good game about their own stock when they get in front of the public. But, how many small company execs do you see actually put their money where their mouth is and buy their own stock? Well, you can see the BioSig Technologies (Nasdaq: BSGM) team has been very active in the market for their own stock lately… I have to say, I was kind of shocked to see this. Usually, when I pull up insider transactions, it is a flood of selling, not buying – and for good reason! Maybe the BSGM guys know something here?? I am running out of room in this email, there are so many strong points I wanted to bring up! But before I wrap this up, I wanted to get into a little more detail about what the company actually does. BioSig Technologies (Nasdaq: BSGM) is an advanced digital signal processing technology company bringing never-before-seen insights to the treatment of cardiovascular arrhythmias. Their PURE EP™ Platform applies a unique combination of hardware and software to accurately capture intracardiac signals with unprecedented clarity and precision. By viewing pure signals that are absent of saturation, interference, or noise from other medical equipment, physicians can respond to even the most complex cardiac arrhythmias with insight-based, highly targeted cardiac ablation procedures. (PURE EP claims to capture critical cardiac signals — even the most complex — to enhance clinical decision-making) BioSig Technologies (Nasdaq: BSGM) operates within the rapidly growing electrophysiology (EP) marketplace – a [market projected to reach $16B]( by 2028 with a 11.2% growth rate (6). They have a signed [Master Research Agreement]( and announced a Multi-System Evaluation Agreement with Cleveland Clinic, … and a signed Purchase Agreement with San Antonio Methodist Hospital. … and a signed Purchase Agreement with Kansas City Rhythm … and a Master Agreement with Hospital Corporation of America ($75 BILLION market cap industry leader) On top of all of that, BSGM even has 50 allowed & issued design and utility patents. There is a lot going on here! While I like BSGM a lot for all of the reasons I mentioned above, I really think you should spend some time doing your own research and learn more about the risks and potential rewards. A great place to start is by visiting their [website](. Good luck, and happy trading! To Your Success, *Please see disclosures below RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 [Manage your email subscriptions.]( DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [(. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT beconstrued as a securities-related offer or solicitation, or be relied upon as personalizedinvestment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securitiesregulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and itsemployees may purchase, sell, or hold long or short positions in securities of the companies mentioned inthis communication. In the event that any suit or action is instituted as a result of doing business with RagingBull.com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled.